DCF — MERCY GILBERT MEDICAL CENTER
Enterprise Value: $177.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$177.4M
Enterprise Value
$42.5M
PV of Cash Flows
$134.9M
PV of Terminal Value
$217.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $393.4M | $26.9M | 7.0% | $6.0M | $5.5M |
| Year 2 | $405.2M | $31.8M | 8.0% | $9.2M | $7.6M |
| Year 3 | $417.3M | $36.9M | 9.0% | $12.6M | $9.5M |
| Year 4 | $429.9M | $40.2M | 9.0% | $14.6M | $10.0M |
| Year 5 | $442.8M | $42.5M | 10.0% | $15.9M | $9.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $177.4M. Terminal value accounts for 76% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$381.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.06349145584334158
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5